Development and Validation of Performance Metrics for Cardiac Device Implant Procedures

Sponsor
Liverpool Heart and Chest Hospital NHS Foundation Trust (Other)
Overall Status
Unknown status
CT.gov ID
NCT03577340
Collaborator
Medtronic (Industry)
16
8.9

Study Details

Study Description

Brief Summary

Cardiac Device implantation includes implantation of pacemakers, implantable defibrillators and Cardiac resynchronisation Therapy (CRT) devices. These are well-established treatments for selected with heart rhythm abnormalities and heart failure.

In the past, trainee doctors had the opportunity to perform many procedures and learn on the patient. This is no longer the case due to a change in training schedules and working times as well as patient safety mandates. Progression based training with the use of simulators has been proven to be effective in training and in order to use this methodology, the procedure needs to be well defined.

Despite its worldwide adoption, a standardized procedure has never been defined in detail and agreed upon and the cardiac device implant technique varies with the operator.

The purpose of the research is to establish the metrics (operational definitions) necessary to characterize a reference Cardiac Device implant procedure.

Condition or Disease Intervention/Treatment Phase
  • Other: implant of cardiac device as per guidelines

Detailed Description

The purpose of the research is to establish the metrics (operational definitions) necessary to characterize a reference Cardiac Device implant procedure, to seek consensus from experienced device implanters on the appropriateness of the steps as well as errors identified, and to determine if such validated performance metrics are a valid assessment tool with the ability to discriminate between the performances of experienced and novice implanters.

These validated metrics will potentially serve as an educational and training tool to improve and quality assure Cardiac device implant training.

The steps involved in characterising a reference procedure are as follows:
  1. Define the implant procedure in quantifiable steps (already performed)

  2. Seek consensus and agreement by an independent panel on the steps (already done).

  3. Video record routinely performed device implants by experienced and novice physicians.

  4. Reviewing and scoring the video recorded procedures to verify that the metrics distinguish between a novice and an expert cardiac device performance.

Study Design

Study Type:
Observational
Anticipated Enrollment :
16 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
Development and Validation of Performance Metrics for Cardiac Device
Anticipated Study Start Date :
Sep 1, 2018
Anticipated Primary Completion Date :
Dec 30, 2018
Anticipated Study Completion Date :
May 30, 2019

Arms and Interventions

Arm Intervention/Treatment
Novices

Novices: Trainee cardiologists implanting cardiac devices as per guidelines under supervision

Other: implant of cardiac device as per guidelines
Observation of performance to validate matrix

Experts

Experts: Device implanting cardiologists implanting cardiac devices as per guidelines

Other: implant of cardiac device as per guidelines
Observation of performance to validate matrix

Outcome Measures

Primary Outcome Measures

  1. The primary outcome measure is the comparison of the intra-operative performance of novices versus experts [6 months]

    The primary analysis will compare the intra-operative performance of novices versus experts. The three experienced cardiac device implanters will test the consented metrics by reviewing and scoring the video recorded procedures to verify that the metrics distinguish between a novice and an expert cardiac device performance. IRR will be considered to be acceptable if it is ≥ 0.8 The primary analysis will compare the intra-operative performance of novices versus experts. The three experienced cardiac device implanters will test the consented metrics by reviewing and scoring the video recorded procedures to verify that the metrics distinguish between a novice and an expert cardiac device performance. IRR will be considered to be acceptable if it is ≥ 0.8

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:

Patients eligible for a cardiac device implant as per current European Society of Cardiology guidelines.

Exclusion Criteria:

Patient< 18 y of age. Patients unable to provide informed written consent for the study.

-

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Liverpool Heart and Chest Hospital NHS Foundation Trust
  • Medtronic

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Archana Rao, Consultant Cardiologist, Liverpool Heart and Chest Hospital NHS Foundation Trust
ClinicalTrials.gov Identifier:
NCT03577340
Other Study ID Numbers:
  • 1189
First Posted:
Jul 5, 2018
Last Update Posted:
Jul 5, 2018
Last Verified:
Jul 1, 2018
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Product Manufactured in and Exported from the U.S.:
No

Study Results

No Results Posted as of Jul 5, 2018